The domiciliary management of genital tract infection.
Present treatment schedules for lower genital tract infections are far from ideal. Members of the 4-quinolone antibiotic class are highly active against Neisseria gonorrhoeae, and some of the newer agents are active against Chlamydia trachomatis. Clinical success has been reported with, for example, a single daily dose of ofloxacin for one week. New macrolides are active against C. trachomatis and N. gonorrhoeae. Azithromycin has been shown to be effective in a single oral dose. The role of newer agents in the therapy of bacterial vaginosis is largely unproven, but there are encouraging signs. The importance of attempting to make a firm diagnosis is emphasized.
Ridgway
G L
GL
Department of Clinical Microbiology, University College Hospital, London, UK.
D000553:Ambulatory Care; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000188:drug therapy; D002692:Chlamydia trachomatis / Q000187:drug effects; D005260:Female; D024841:Fluoroquinolones; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D018942:Macrolides; D012749:Sexually Transmitted Diseases / Q000188:drug therapy*; D013587:Syphilis / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D018942:Macrolides